HRP20181118T1 - Mjerenje autoprotutijela u uvjetima niske vodljivosti - Google Patents

Mjerenje autoprotutijela u uvjetima niske vodljivosti

Info

Publication number
HRP20181118T1
HRP20181118T1 HRP20181118TT HRP20181118T HRP20181118T1 HR P20181118 T1 HRP20181118 T1 HR P20181118T1 HR P20181118T T HRP20181118T T HR P20181118TT HR P20181118 T HRP20181118 T HR P20181118T HR P20181118 T1 HRP20181118 T1 HR P20181118T1
Authority
HR
Croatia
Prior art keywords
protibodies
auto
measurement
under low
low conductivity
Prior art date
Application number
HRP20181118TT
Other languages
English (en)
Croatian (hr)
Inventor
Alfred Weber
Andrea ENGELMAIER
Hans-Peter Schwarz
Original Assignee
Baxalta GmbH
Baxalta Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Incorporated filed Critical Baxalta GmbH
Publication of HRP20181118T1 publication Critical patent/HRP20181118T1/hr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HRP20181118TT 2011-12-13 2012-12-13 Mjerenje autoprotutijela u uvjetima niske vodljivosti HRP20181118T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161570211P 2011-12-13 2011-12-13
EP12820994.7A EP2791675B1 (en) 2011-12-13 2012-12-13 Measurement of autoantibodies in low conductivity conditions
PCT/US2012/069587 WO2013090636A1 (en) 2011-12-13 2012-12-13 Measurement of autoantibodies at low conductivity conditions with increased sensitivity

Publications (1)

Publication Number Publication Date
HRP20181118T1 true HRP20181118T1 (hr) 2018-09-21

Family

ID=47630506

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181118TT HRP20181118T1 (hr) 2011-12-13 2012-12-13 Mjerenje autoprotutijela u uvjetima niske vodljivosti

Country Status (14)

Country Link
US (1) US9075069B2 (enExample)
EP (1) EP2791675B1 (enExample)
JP (1) JP6333731B2 (enExample)
KR (1) KR20140104479A (enExample)
AR (1) AR089233A1 (enExample)
AU (1) AU2012321074B2 (enExample)
DK (1) DK2791675T3 (enExample)
ES (1) ES2685332T3 (enExample)
HR (1) HRP20181118T1 (enExample)
HU (1) HUE038441T2 (enExample)
PL (1) PL2791675T3 (enExample)
PT (1) PT2791675T (enExample)
TW (1) TW201339578A (enExample)
WO (1) WO2013090636A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
US20160168235A1 (en) * 2013-07-19 2016-06-16 Board Of Regents Of The University Of Texas System Transthyretin amyloid-selective and polyreactive catabodies
SI24638A (sl) 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
RU2017107273A (ru) * 2014-08-08 2018-09-10 Аллегени-Сингер Рисерч Инститьют Антилимфоцитарные аутоантитела в качестве диагностических биомаркеров
EP3329278A4 (en) 2015-07-31 2019-01-16 Allegheny-Singer Research Institute CELL-ASSOCIATED COMPLEMENT ACTIVATION PRODUCTS AS COMPARATIVE DIAGNOSTICS FOR ANTIBODY-BASED MEDICAMENTS
KR20170108203A (ko) * 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
CN108169303B (zh) * 2017-12-07 2019-08-20 商丘师范学院 基于金属有机框架材料作为信号探针的核酸适配体电化学传感器
US12436148B2 (en) 2018-07-02 2025-10-07 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
JP7268306B2 (ja) * 2018-08-31 2023-05-08 東洋紡株式会社 生体試料中の測定対象物質を免疫学的に測定する方法
JP7356128B2 (ja) * 2019-06-07 2023-10-04 慶應義塾 自己免疫疾患の検出剤となるタンパク質複合体、及びその使用
CN113759107A (zh) * 2021-08-18 2021-12-07 苏州立禾生物医学工程有限公司 生物素标记缓冲液
CN117347616A (zh) * 2022-06-27 2024-01-05 菲鹏生物股份有限公司 稀释剂、捕获试剂、检测试剂盒和测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259207A (en) 1979-09-19 1981-03-31 American Hospital Supply Corporation Suspending medium for immunologic reactions
JPS57182168A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Immunochemical reagent
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5763158A (en) 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
US6958244B2 (en) * 2002-04-12 2005-10-25 Bruker Biospin Corp. Low-conductivity buffers for magnetic resonance measurements
ES2661168T3 (es) * 2003-07-12 2018-03-27 Accelerate Diagnostics, Inc. Biodetección sensible y rápida
AU2008286361B2 (en) 2007-08-13 2013-09-26 Takeda Pharmaceutical Company Limited IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease
US8852874B2 (en) 2008-02-29 2014-10-07 Baxter International Inc. Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
CN102341707B (zh) * 2009-03-05 2014-05-07 电化生研株式会社 检测试剂以及使用该检测试剂测定检测样品中的被测定物的方法
CN102449483A (zh) * 2009-03-31 2012-05-09 日本烟草产业株式会社 对生物学样品中的sith-1抗体进行检测的方法
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
DK2791675T3 (da) 2018-07-30
EP2791675B1 (en) 2018-04-25
TW201339578A (zh) 2013-10-01
WO2013090636A1 (en) 2013-06-20
PT2791675T (pt) 2018-07-27
US9075069B2 (en) 2015-07-07
ES2685332T3 (es) 2018-10-08
AU2012321074B2 (en) 2015-12-03
EP2791675A1 (en) 2014-10-22
JP6333731B2 (ja) 2018-05-30
AR089233A1 (es) 2014-08-06
KR20140104479A (ko) 2014-08-28
JP2015500502A (ja) 2015-01-05
US20130149700A1 (en) 2013-06-13
HUE038441T2 (hu) 2018-10-29
PL2791675T3 (pl) 2018-10-31
AU2012321074A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
EP3736578C0 (en) CURRENT MEASUREMENT
PL2831279T3 (pl) Szybkie wykrywanie aneuploidii
DK2649468T3 (da) Ultralydsmåling
DK4049581T3 (da) Fjernmonitorering af analytmålinger
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
EP2713762A4 (en) Stevia-COMPOSITION
EP2673344A4 (en) STABLE BIO OIL
BR112014001420A2 (pt) uso de pelotas extrusadas
DK3002135T3 (da) Bugseringsenhed
FR2975488B1 (fr) Capteur
JP2011209285A5 (ja) 力測定システム
HUE038441T2 (hu) Autoantitestek mérése alacsony vezetõképességû körülmények között
NO343662B1 (no) Strømningsmåling
EP2744740A4 (en) BOOM STRUCTURE
FI20116329L (fi) Mittauskohteen mittaus
EP2661633A4 (en) Proteolysis detection
PT2793883T (pt) Antagonistas de trpm8
BR112013029333A2 (pt) detecção de nível
EP2795304A4 (en) ELECTROCHEMICAL SENSORS
EP2778639A4 (en) Platinum-based thermocouple
BR112013032459A2 (pt) indicação de material estranho
HRP20182057T1 (hr) Temperaturno stabilni vodeni pripravci klokintocet-meksila
EP2747208A4 (en) TERMINAL